|
FR2528434B1
(fr)
|
1982-06-11 |
1985-07-19 |
Roussel Uclaf |
Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
|
|
ZA8231B
(en)
|
1981-01-09 |
1982-11-24 |
Roussel Uclaf |
New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
|
|
FR2522328B1
(fr)
|
1982-03-01 |
1986-02-14 |
Roussel Uclaf |
Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
|
|
JP2785023B2
(ja)
|
1987-12-30 |
1998-08-13 |
ルセル―ユクラフ |
１７α位置を置換された１７β―ＯＨ―１９―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
|
|
EP0369881A1
(fr)
|
1988-11-16 |
1990-05-23 |
Roussel-Uclaf |
Nouveaux produits dérivés de la structure 3-céto delta-4,9 19-nor stéroides et leur application comme médicaments
|
|
DE3921059A1
(de)
|
1989-06-23 |
1991-01-10 |
Schering Ag |
11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
|
|
FR2651435A1
(fr)
|
1989-09-07 |
1991-03-08 |
Roussel Uclaf |
Nouvelle utilisation de composes anti-progestomimetiques.
|
|
DE4018167A1
(de)
*
|
1990-06-01 |
1991-12-05 |
Schering Ag |
Verfahren zur herstellung von 10(beta)-h-steroiden
|
|
DE4042007A1
(de)
|
1990-12-22 |
1992-06-25 |
Schering Ag |
6,7-modifizierte-11(beta)-aryl-4-estrene
|
|
EP0712311B1
(en)
|
1993-08-04 |
1998-10-07 |
Akzo Nobel N.V. |
Antiglucocorticoid steroids for the treatment of anxiety disorders
|
|
AU1439595A
(en)
|
1993-12-22 |
1995-07-10 |
Salk Institute For Biological Studies, The |
Methods for reducing multidrug resistance
|
|
SK282570B6
(sk)
|
1995-02-02 |
2002-10-08 |
Schering Aktiengesellschaft |
Antagonisty progesterónu na výrobu liekov na ošetrenie dysfunkčného maternicového krvácania
|
|
IL118974A
(en)
*
|
1995-08-17 |
2001-09-13 |
Akzo Nobel Nv |
History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
|
|
IL122740A
(en)
|
1997-01-15 |
2003-09-17 |
Akzo Nobel Nv |
16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them
|
|
CN1085078C
(zh)
*
|
1998-01-07 |
2002-05-22 |
沈志华 |
用于大月份引产的复合药物
|
|
US6512130B1
(en)
*
|
2000-09-05 |
2003-01-28 |
Council Of Scientific And Industrial Research |
Mifepristone analogue, process for the preparation thereof and use thereof
|
|
EP1285927A3
(de)
|
2001-08-16 |
2005-06-29 |
Schering Aktiengesellschaft |
Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems
|
|
US7250408B2
(en)
*
|
2002-12-16 |
2007-07-31 |
Bayer Schering Pharma Ag |
Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility
|
|
SI1989218T1
(sl)
|
2006-02-17 |
2010-04-30 |
Janssen Pharmaceutica Nv |
17- fosforjevi steroidni derivati, koristni kot progesteronski receptorski modulatorji
|
|
NZ572374A
(en)
|
2006-03-29 |
2011-12-22 |
Univ California |
Diarylthiohydantoin compounds
|
|
HRP20160689T1
(hr)
|
2007-04-20 |
2016-07-15 |
Preglem S.A. |
Selektivni modulatori progesterona za tretman uterinog krvarenja
|
|
EP2671086B1
(en)
|
2011-02-03 |
2018-04-25 |
Pop Test Oncology LLC |
System and method for diagnosis and treatment
|
|
EP2545922A1
(en)
|
2011-07-12 |
2013-01-16 |
PregLem S.A. |
Treatment of excessive menstrual bleeding associated with uterine fibroids
|
|
US20130029953A1
(en)
|
2011-07-28 |
2013-01-31 |
Klaus Nickisch |
Progesterone antagonists
|
|
PT3111950T
(pt)
|
2012-02-24 |
2021-10-19 |
Univ Chicago |
Métodos e composições relacionadas com antagonismo recetor de glucocorticoide e cancro da próstata
|
|
EP2641602A1
(en)
|
2012-03-23 |
2013-09-25 |
PregLem S.A. |
Method for treating gynecological diseases
|
|
US9096641B2
(en)
|
2013-06-05 |
2015-08-04 |
Evestra, Inc. |
Imidazolyl progesterone antagonists
|
|
WO2015089338A2
(en)
|
2013-12-11 |
2015-06-18 |
Sloan-Kettering Institute For Cancer Research |
Glucocorticoid inhibitors for treatment of prostate cancer
|
|
CN104530166B
(zh)
|
2014-12-04 |
2016-08-24 |
陕西汉江药业集团股份有限公司 |
选择性还原4,6-共轭双烯-3-酮甾体化合物的方法
|
|
US11110103B2
(en)
|
2015-12-23 |
2021-09-07 |
Oric Pharmaceuticals, Inc. |
Inhibitors of glucocorticoid receptor
|
|
US11208432B2
(en)
*
|
2015-12-23 |
2021-12-28 |
Oric Pharmaceuticals, Inc. |
Inhibitors of glucocorticoid receptor
|
|
WO2017112902A1
(en)
|
2015-12-23 |
2017-06-29 |
Oric Pharmaceuticals, Inc. |
Inhibitors of glucocorticoid receptor
|
|
PL3523315T3
(pl)
|
2016-10-07 |
2021-10-18 |
Oric Pharmaceuticals, Inc. |
Inhibitor receptora glukokortykoidowego
|
|
US12233073B2
(en)
|
2017-06-09 |
2025-02-25 |
Regents Of The University Of Minnesota |
Skin care formulations and skin cancer treatment
|
|
CN112272552A
(zh)
|
2018-04-11 |
2021-01-26 |
欧瑞克制药公司 |
包含糖皮质激素受体拮抗剂的固体形式和制剂及其用途
|